These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7495215)

  • 1. Microvascular angina in systemic hypertension: diagnosis and treatment with enalapril.
    Iriarte MM; Caso R; Murga N; López de Argumedo M; Sagastagoitia D
    Am J Cardiol; 1995 Nov; 76(13):31D-34D. PubMed ID: 7495215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril-induced regression of hypertensive left ventricular hypertrophy, regional ischemia, and microvascular angina.
    Iriarte M; Caso R; Murga N; Boveda J; Saenz R; Lopez de Argumedo M; Gonzalez J; Uriarte P; Ormaetxe J
    Am J Cardiol; 1995 Apr; 75(12):850-2. PubMed ID: 7717299
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
    Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
    G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy.
    Iriarte M; Caso R; Murga N; Faus JM; Sagastagoitia D; Molinero E; López de Argumedo M; Boveda J
    Am J Cardiol; 1995 Feb; 75(5):335-9. PubMed ID: 7856523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of coronary flow reserve after long-term therapy with enalapril.
    Motz W; Strauer BE
    Hypertension; 1996 May; 27(5):1031-8. PubMed ID: 8621193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophy and coronary reserve].
    Motz W; Scheler S
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S257-60. PubMed ID: 19085802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE-inhibitors and coronary microcirculation.
    Strauer BE; Vogt M; Motz W
    Basic Res Cardiol; 1993; 88 Suppl 1():97-106. PubMed ID: 8357338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group.
    Diamond JA; Gharavi A; Roychoudhury D; Machac J; Henzlova MJ; Travis A; Phillips RA
    Curr Med Res Opin; 1999; 15(1):1-8. PubMed ID: 10216805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined heart protection for the hypertensive patient].
    MMW Fortschr Med; 2013 Jan; 155(1):66-7. PubMed ID: 23573728
    [No Abstract]   [Full Text] [Related]  

  • 10. Organ protection: benefit from antihypertensive treatment?
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S50-4. PubMed ID: 7898094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Open trial using ACE inhibitor. Left ventricular hypertrophy diminishes].
    Arend U; Albrecht S; Meisel E; Schmidt J
    MMW Fortschr Med; 2002 Nov; 144(48):51. PubMed ID: 12532545
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of angiotensin-converting enzyme inhibitors in patients with ischemic heart disease].
    Martsevich SIu; Metelitsa VI; Vakulovskaia MK; Kozyreva MP
    Kardiologiia; 1993; 33(3):58-60. PubMed ID: 8377343
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance.
    Leonetti G; Fogari R; Mazzola C; Pasotti C; Ponti GB; Marelli C; Zanchetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S356-7. PubMed ID: 8158420
    [No Abstract]   [Full Text] [Related]  

  • 16. Enalaprilat improves the impaired left ventricular pump function during exercise in hypertensives with coronary microangiopathy and with coronary artery disease.
    Franz I; Tönnesmann U; Schaupp S; van der Meyden J
    Kidney Blood Press Res; 1998; 21(6):452-8. PubMed ID: 9933831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG; Serbul VM; Ageev FT
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular hypertrophy by spirapril.
    Eichstädt H; Sierakowski B; Eskötter H; Cordes M; Kreuz D
    Blood Press Suppl; 1994; 2():93-4. PubMed ID: 8061856
    [No Abstract]   [Full Text] [Related]  

  • 20. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists.
    Vogt M; Strauer BE
    Am J Cardiol; 1995 Nov; 76(13):24D-30D. PubMed ID: 7495214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.